Chen, L.; Yang, D.; Yusufu, Y.; Liu, H.; Liu, M.; Lin, Y.; Luo, Y.; He, Q.; Chen, M.; Zeng, Z.;
et al. Trans-Arterial Embolization for Liver Metastases of Gastroenteropancreatic Neuroendocrine Tumors: Response Indicates Survival Benefit? Cancers 2025, 17, 309.
https://doi.org/10.3390/cancers17020309
AMA Style
Chen L, Yang D, Yusufu Y, Liu H, Liu M, Lin Y, Luo Y, He Q, Chen M, Zeng Z,
et al. Trans-Arterial Embolization for Liver Metastases of Gastroenteropancreatic Neuroendocrine Tumors: Response Indicates Survival Benefit? Cancers. 2025; 17(2):309.
https://doi.org/10.3390/cancers17020309
Chicago/Turabian Style
Chen, Luohai, Dequan Yang, Yueriguli Yusufu, Haikuan Liu, Man Liu, Yuan Lin, Yanji Luo, Qiao He, Minhu Chen, Zhirong Zeng,
and et al. 2025. "Trans-Arterial Embolization for Liver Metastases of Gastroenteropancreatic Neuroendocrine Tumors: Response Indicates Survival Benefit?" Cancers 17, no. 2: 309.
https://doi.org/10.3390/cancers17020309
APA Style
Chen, L., Yang, D., Yusufu, Y., Liu, H., Liu, M., Lin, Y., Luo, Y., He, Q., Chen, M., Zeng, Z., Zhang, N., & Wang, Y.
(2025). Trans-Arterial Embolization for Liver Metastases of Gastroenteropancreatic Neuroendocrine Tumors: Response Indicates Survival Benefit? Cancers, 17(2), 309.
https://doi.org/10.3390/cancers17020309